Skip to main content
Article thumbnail
Location of Repository

A rush to judgment on Th17

By Lawrence Steinman


Some immunologists have characterized T helper (Th)17 T cells as the master mediators of tissue damage in a variety of pathological conditions. New data now demonstrate that Th1 and Th17 T cells are independently capable of inducing disease in two established models of autoimmunity. Thus, the role of Th17 cytokines as the central mediators of pathological tissue damage seems to require clarification

Topics: Commentaries
Publisher: The Rockefeller University Press
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2007). A brief history of TH17, the fi rst major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage.
    2. a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells.
    3. (2000). A novel transcription factor,
    4. (2008). Diff erential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
    5. (2001). Eff ect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.
    6. (2008). Either a Th17 or a Th1 eff ector response can drive autoimmunity: conditions of disease induction aff ect dominant eff ector category.
    7. (1988). Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.
    8. (2006). for initiation of autoimmune encephalomyelitis.
    9. (2008). IL-17 receptor signaling infl uences viral induced corneal infl ammation.
    10. (2008). immunopathogenic but diff er in other key biological activities.
    11. (2008). Interleukin-17 production in central nervous system-infi ltrating T cells and glial cells is associated with active disease in multiple sclerosis.
    12. (2004). Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.
    13. (1996). Mice with a disrupted interferon-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
    14. microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
    15. (2006). Molecular characterization of human adenomyosis.
    16. (1996). Mouse IL-
    17. (2006). Origins of the T(H)1-T(H)2 model: a personal perspective.
    18. (2008). profi le, and response to immunomodulatory intervention.
    19. (2008). Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
    20. (2004). Silencing T-bet defi nes a critical role in the diff erentiation of autoreactive T lymphocytes.
    21. (2008). suppresses Th17 cytokines secreted by macrophages and T cells.
    22. (1990). Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferongamma in Lewis rats.
    23. T(H)-17 cells in the circle of immunity and autoimmunity.
    24. (2006). The orphan nuclear receptor RORgammaT directs the diff erentiation program of proinfl ammatory IL-17+ T helper cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.